Literature DB >> 20402465

Biological in vitro and in vivo studies of a series of new asymmetrical cationic [99mTc(N)(DTC-Ln)(PNP)]+ complex (DTC-Ln = alicyclic dithiocarbamate and PNP = diphosphinoamine).

Cristina Bolzati1, Mario Cavazza-Ceccato, Stefania Agostini, Fiorenzo Refosco, Yoshihiro Yamamichi, Shinji Tokunaga, Davide Carta, Nicola Salvarese, Daniele Bernardini, Giuliano Bandoli.   

Abstract

(99m)Tc(N)-DBODC5 is a cationic mixed compound under clinical investigation as potential myocardial imaging agent. In spite of this, analogously to the other cationic (99m)Tc-agents, presents a relatively low first-pass extraction. Thus, modification of (99m)Tc(N)-DBODC(5) direct to increase its first-pass extraction keeping unaltered the favorable imaging properties would be desirable. This work describes the synthesis and biological evaluation of a series of novel cationic (99m)Tc-nitrido complexes, of general formula [(99m)TcN(DTC-Ln)(PNP)](+) (DTC-Ln= alicyclic dithiocarbamates; PNP = diphosphinoamine), as potential radiotracers for myocardial perfusion imaging. The synthesis of cationic (99m)Tc-(N)-complexes were accomplished in two steps. Biodistribution studies were performed in rats and compared with the distribution profiles of (99m)Tc(N)-DBODC5 and (99m)Tc-Sestamibi. The metabolisms of the most promising compounds were evaluated by HPLC methods. Biological studies revealed that most of the complexes have a high initial and persistent heart uptake with rapid clearance from nontarget tissues. Among tested compounds, 2 and 12 showed improved heart uptake with respect to the gold standard (99m)Tc-complexes with favorable heart-to-liver and slightly lower heart-to-lung ratios. Chromatographic profiles of (99m)Tc(N)-radioactivity extracted from tissues and fluids were coincident with the native compound evidencing remarkable in vivo stability of these agents. This study shows that the incorporation of alicyclic dithiocarbamate in the [(99m)Tc(N)(PNP)](+) building block yields to a significant increase of the heart uptake at early injection point suggesting that the first-pass extraction fraction of these novel complexes may be increased with respect to the other cationic (99m)Tc-agents keeping almost unaltered the favorable target/nontarget ratios.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20402465     DOI: 10.1021/bc900493e

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  6 in total

1.  Novel SPECT perfusion imaging agents with improved myocardial or liver kinetics: experimental studies and the need for clinical evaluation.

Authors:  Laurent M Riou; Alexis Broisat
Journal:  J Nucl Cardiol       Date:  2010-10       Impact factor: 5.952

2.  (99m)Tc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study.

Authors:  Cristina Bolzati; Davide Carta; Valentina Gandin; Cristina Marzano; Nicolò Morellato; Nicola Salvarese; Mariangela Cantore; Nicola Antonio Colabufo
Journal:  J Biol Inorg Chem       Date:  2013-03-31       Impact factor: 3.358

Review 3.  Dithiocarbamate complexes as radiopharmaceuticals for medical imaging.

Authors:  David J Berry; Rafael Torres Martin de Rosales; Putthiporn Charoenphun; Philip J Blower
Journal:  Mini Rev Med Chem       Date:  2012-10       Impact factor: 3.862

Review 4.  Technetium-99m Radiopharmaceuticals for Ideal Myocardial Perfusion Imaging: Lost and Found Opportunities.

Authors:  Alessandra Boschi; Licia Uccelli; Lorenza Marvelli; Corrado Cittanti; Melchiore Giganti; Petra Martini
Journal:  Molecules       Date:  2022-02-10       Impact factor: 4.411

Review 5.  A Review on the Current State and Future Perspectives of [99mTc]Tc-Housed PSMA-i in Prostate Cancer.

Authors:  Sara Brunello; Nicola Salvarese; Debora Carpanese; Carolina Gobbi; Laura Melendez-Alafort; Cristina Bolzati
Journal:  Molecules       Date:  2022-04-19       Impact factor: 4.927

6.  Impact of Different [Tc(N)PNP]-Scaffolds on the Biological Properties of the Small cRGDfK Peptide: Synthesis, In Vitro and In Vivo Evaluations.

Authors:  Nicola Salvarese; Debora Carpanese; Laura Meléndez-Alafort; Laura De Nardo; Andrea Calderan; Barbara Biondi; Paolo Ruzza; Antonio Rosato; Cristina Bolzati
Journal:  Molecules       Date:  2022-04-14       Impact factor: 4.927

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.